GeneDx Holdings Corp. is delivering strong revenue growth, but it is still burning cash. Click here for more on WGS stock ...

Multiscore, a Gene Ranker Powered by Artificial Intelligence and Real-World Clinical Data, Shows High Sensitivity in 10,000 Exomes and Genomes will be presented by Vinnie Ustach, PhD (GeneDx) on ...

We recently compiled a list of the 10 Best Emerging Technology Stocks to Buy Now. In this article, we are going to take a ...

Learn more about whether Alignment Healthcare, Inc. or GeneDx Holdings Corp. is a better investment based on AAII's A+ ...

Learn more about whether LifeStance Health Group, Inc. or GeneDx Holdings Corp. is a better investment based on AAII's A+ ...

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and ...

NEW YORK, NY / / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...

Principal Financial Group Inc. raised its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 10.6% in the ...

TD Cowen raised the firm’s price target on GeneDx (WGS) to $135 from $118 and keeps a Buy rating on the shares. The firm said they provided solid guidance but a focus in 2025 will be both ...

March is Cerebral Palsy Awareness Month. Dr. Paul Kruszka is Chief Medical Officer at GeneDx, a commercial laboratory ...

GAITHERSBURG, Md., February 18, 2025--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial ...

GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the fourth quarter and full year of 2024.